Evaluation of effectiveness and safety of delamanid-containing regimens using individual patient datasets

Int J Tuberc Lung Dis. 2024 Sep 1;28(9):470-472. doi: 10.5588/ijtld.24.0317.

¹ Faculdade de Medicina, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
² Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici MaugeriIRCCS, Tradate Italy.
³ Public Health Consulting Group, Lugano, Switzerland.
⁴ Department of Medicine and Surgery, University of Insubria, Varese, Italy;, Department of Medicine and Cardiopulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
⁵ Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
⁶ Department of Pulmonary Diseases and Tuberculosis, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands;, University Medical Center Groningen, TB Center Beatrixoord, University of Groningen, Haren, the Netherlands.
⁷ UCL Respiratory, University College London, UK;, Royal Free London NHS Foundation Trust, London, UK.

No abstract available

Publication types